150 related articles for article (PubMed ID: 17045980)
1. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F
Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
[TBL] [Abstract][Full Text] [Related]
2. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
[TBL] [Abstract][Full Text] [Related]
3. Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.
Nishizawa Y; Inaba M; Ishii M; Yamashita H; Miki T; Goto H; Yamada S; Chaki O; Kurasawa K; Mochizuki Y
J Bone Miner Metab; 2008; 26(3):265-70. PubMed ID: 18470668
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Qin YJ; Zhang ZL; Zhang H; Hu WW; Liu YJ; Hu YQ; Li M; Gu JM; He JW
Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169
[TBL] [Abstract][Full Text] [Related]
5. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
[TBL] [Abstract][Full Text] [Related]
6. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
7. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
[TBL] [Abstract][Full Text] [Related]
8. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
Halleen JM; Karp M; Viloma S; Laaksonen P; Hellman J; Käkönen SM; Stepan JJ; Holmes S; Väänänen Hk; Pettersson K
J Bone Miner Res; 1999 Mar; 14(3):464-9. PubMed ID: 10027912
[TBL] [Abstract][Full Text] [Related]
9. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
[TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
11. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
[TBL] [Abstract][Full Text] [Related]
12. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
[TBL] [Abstract][Full Text] [Related]
13. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)].
Mochizuki Y
Clin Calcium; 2006 Jun; 16(6):948-55. PubMed ID: 16751690
[TBL] [Abstract][Full Text] [Related]
14. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Yao NS; Wu YY; Janckila AJ; Ku CH; Hsieh AT; Ho CL; Lee SH; Chao TY
Clin Chim Acta; 2011 Jan; 412(1-2):181-5. PubMed ID: 20932965
[TBL] [Abstract][Full Text] [Related]
15. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Janckila AJ; Simons RM; Yam LT
Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
[TBL] [Abstract][Full Text] [Related]
16. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
17. Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase.
Pradella SD; Slone SP; Wu YY; Chao TY; Parthasarathy RN; Yam LT; Janckila AJ
J Immunol Methods; 2011 Sep; 372(1-2):162-70. PubMed ID: 21787778
[TBL] [Abstract][Full Text] [Related]
18. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.
Nakasato YR; Janckila AJ; Halleen JM; Vaananen HK; Walton SP; Yam LT
Clin Chem; 1999 Dec; 45(12):2150-7. PubMed ID: 10585347
[TBL] [Abstract][Full Text] [Related]
20. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
Halleen JM; Hentunen TA; Karp M; Käkönen SM; Pettersson K; Väänänen HK
J Bone Miner Res; 1998 Apr; 13(4):683-7. PubMed ID: 9556068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
